Cross-Omics Identification and Validation of PCSK9 as a Candidate Molecule Associated with Aortic Dissection and Negative Remodeling After TEVAR.

Fang S, Yang C, Fang J, Ding Y, Li X, Xie T, Zhou Z, Zhou M, Shi Z

Open source

DOI
10.3390/jcdd13090442
Published
2026 Sep 7
Container
Journal of cardiovascular development and disease
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcdd13090442,
  title = {Cross-Omics Identification and Validation of PCSK9 as a Candidate Molecule Associated with Aortic Dissection and Negative Remodeling After TEVAR.},
  author = {Fang S and Yang C and Fang J and Ding Y and Li X and Xie T and Zhou Z and Zhou M and Shi Z},
  year = {2026},
  journal = {Journal of cardiovascular development and disease},
  doi = {10.3390/jcdd13090442},
  url = {https://doi.org/10.3390/jcdd13090442}
}

RIS

TY  - JOUR
TI  - Cross-Omics Identification and Validation of PCSK9 as a Candidate Molecule Associated with Aortic Dissection and Negative Remodeling After TEVAR.
AU  - Fang S
AU  - Yang C
AU  - Fang J
AU  - Ding Y
AU  - Li X
AU  - Xie T
AU  - Zhou Z
AU  - Zhou M
AU  - Shi Z
PY  - 2026
JO  - Journal of cardiovascular development and disease
DO  - 10.3390/jcdd13090442
UR  - https://doi.org/10.3390/jcdd13090442
ER  - 

APA

S, F., C, Y., J, F., Y, D., X, L., T, X., Z, Z., M, Z., & Z, S. (2026). Cross-Omics Identification and Validation of PCSK9 as a Candidate Molecule Associated with Aortic Dissection and Negative Remodeling After TEVAR.. Journal of cardiovascular development and disease. https://doi.org/10.3390/jcdd13090442

Source records